BEAM
Beam Therapeutics Inc
Price:  
16.01 
USD
Volume:  
2,476,878.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BEAM Fair Value

-223.79 %
Upside

What is the fair value of BEAM?

As of 2025-08-22, the Fair Value of Beam Therapeutics Inc (BEAM) is -19.82 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 16.01 USD, the upside of Beam Therapeutics Inc is -223.79%.

Is BEAM a good investment?

With the market price of 16.01 USD and our fair value calculation, Beam Therapeutics Inc (BEAM) is not a good investment. Investing in BEAM stocks now will result in a potential loss of 223.79%.

Note: valuation result may not be accurate due to the company's negative EPS.

16.01 USD
Stock Price
-19.82 USD
Fair Price
FAIR VALUE CALCULATION

BEAM Fair Value

Peter Lynch's formula is:

BEAM Fair Value
= Earnings Growth Rate x TTM EPS
BEAM Fair Value
= 5.00 x -3.96
BEAM Fair Value
= -19.82

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -194.59 -370.64 -289.09 -132.53 -376.74 -272.72
YoY growth -148.42% -90.47% 22.00% 54.16% -184.28% -69.40%

BEAM Fair Value - Key Data

Market Cap (mil) 1,609.97
P/E
Forward P/E
EPS -3.96
Avg earnings growth rate -69.40%
TTM earnings -398.58